Matthew Hudes is U.S. Managing Principal, Biotechnology, for Deloitteâ€™s Life Sciences & Health Care practice. In this role, he develops, provides and leads the practiceâ€™s professional services, working with Tax, Audit, Consulting, and Financial Advisory Services, for this dynamic industry sector. Previously, he was the Chairman and CEO of AccÃ©lÃ¨re, a software company that developed a system to find patients (and investigators) for clinical trials and to improve researchersâ€™ access to information typically â€œtrappedâ€ in laboratory and medical systems.
Matthew has provided strategic professional services to leading biotechnology and pharmaceutical companies, including Amgen, Amylin, Biogen Idec, Chiron, Genentech, Gilead, Johnson & Johnson, and Sanofi-Aventis. He speaks frequently about topics such as the use of technology for innovating clinical research, manufacturing and quality, regulatory compliance, and supply chain.
Formerly, Matthew led the global Capgemini Life Sciences Biotechnology and R&D practice. As a former Partner and practice leader with Ernst & Young LLP, he acted as a strategic advisor to leading-edge companies in life sciences and high technology over a period of 17 years. Matthew was a founding management team member of three start-up companies, one of which had a successful IPO and was subsequently acquired. The other two were successfully acquired by larger companies.